REAP Financial Group, LLC

Position in AVIR — Atea Pharmaceuticals, Inc.

CIK 2048581 AUSTIN, TX

Position in AVIR

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$465

-$73 QoQ

Shares Held

100

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#118

of 124 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

REAP Financial Group, LLC holds $91,926 across 3 Biotechnology names. AVIR ranks #2 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	184	$91,398
2	AVIR	Atea Pharmaceuticals, Inc. This page	100	$465
3	FBRX	Forte Biosciences, Inc.	3	$63

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$465	100	0.0%	Shares	Sole	2026-08-04
2026-03-31	$538	100	—	Shares	Sole	2026-05-11
No filing history on record for this holder in this stock.